BOBBY SMITH: Open Payments
NPI 1427556679 · ALBERTVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,889 in 93 payments from 15 companies in 2025. Trend: 2023 $4,557 · 2024 $4,756 · 2025 $1,889
Food & beverage: $1,820Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $510 |
| Novartis Pharmaceuticals Corporation | 16 | $320 |
| GlaxoSmithKline, LLC. | 15 | $249 |
| Janssen Biotech, Inc. | 7 | $196 |
| E.R. Squibb & Sons, L.L.C. | 7 | $159 |
| GENZYME CORPORATION | 4 | $115 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| UCB, Inc. | 3 | $59 |
| Amgen Inc. | 3 | $49 |
| PFIZER INC. | 2 | $44 |
Products named: RINVOQ, COSENTYX, BENLYSTA, TREMFYA, ORENCIA, SKYRIZI, KEVZARA, SAPHNELO.
Industry payments across AL — which companies pay providers there.
